|
|
|
|
pmid:
|
Okudaira N et al. |
Up-regulation of carnitine transporters helps maintain tissue carnitine levels in carnitine deficiency induced by pivalic acid. |
2001 |
Pharm. Res. |
pmid:11451029
|
Brass EP |
Pivalate-generating prodrugs and carnitine homeostasis in man. |
2002 |
Pharmacol. Rev. |
pmid:12429869
|
Konishi M and Hashimoto H |
Determination of pivaloylcarnitine in human plasma and urine by high-performance liquid chromatography with fluorescence detection. |
1992 |
J Pharm Sci |
pmid:1432617
|
Totsuka K et al. |
Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1503437
|
Nakashima M et al. |
Phase I clinical studies of S-1108: safety and pharmacokinetics in a multiple-administration study with special emphasis on the influence on carnitine body stores. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1503438
|
Yamaguchi T et al. |
Possible mechanism for species difference on the toxicity of pivalic acid between dogs and rats. |
2006 |
Toxicol. Appl. Pharmacol. |
pmid:16430936
|
Okamura N et al. |
Involvement of recognition and interaction of carnitine transporter in the decrease of L-carnitine concentration induced by pivalic acid and valproic acid. |
2006 |
Pharm. Res. |
pmid:16826461
|
Ohnishi S et al. |
Role of Na+/L-carnitine transporter (OCTN2) in renal handling of pivaloylcarnitine and valproylcarnitine formed during pivalic acid-containing prodrugs and valproic acid treatment. |
2008 |
Drug Metab. Pharmacokinet. |
pmid:18762717
|
Todesco L et al. |
Interaction between pivaloylcarnitine and L-carnitine transport into L6 cells overexpressing hOCTN2. |
2009 |
Chem. Biol. Interact. |
pmid:19539806
|